Progress of nanopreparation technology applied to volatile oil drug delivery systems.

Application Nanopreparation technology Research progress Volatile oil

Journal

Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560

Informations de publication

Date de publication:
30 Jan 2024
Historique:
received: 20 10 2023
revised: 04 01 2024
accepted: 05 01 2024
medline: 31 1 2024
pubmed: 31 1 2024
entrez: 31 1 2024
Statut: epublish

Résumé

Traditional Chinese medicine volatile oil has a long history and possesses extensive pharmacological activity. However, volatile oils have characteristics such as strong volatility, poor water solubility, low bioavailability, and poor targeting, which limit their application. The use of volatile oil nano drug delivery systems can effectively improve the drawbacks of volatile oils, enhance their bioavailability and chemical stability, and reduce their volatility and toxicity. This article first introduces the limitations of the components of traditional Chinese medicine volatile oils, discusses the main classifications and latest developments of volatile oil nano formulations, and briefly describes the preparation methods of traditional Chinese medicine volatile oil nano formulations. Secondly, the limitations of nano formulation technology are discussed, along with future challenges and prospects. A deeper understanding of the role of nanotechnology in traditional Chinese medicine volatile oils will contribute to the modernization of volatile oils and broaden their application value.

Identifiants

pubmed: 38293491
doi: 10.1016/j.heliyon.2024.e24302
pii: S2405-8440(24)00333-5
pmc: PMC10825498
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

e24302

Informations de copyright

© 2024 Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Zu-Wen Ye (ZW)

Cancer Research Centre, Jiangxi University of Chinese Medicine, 330004, China.

Qi-Yue Yang (QY)

Affiliated Hospital of Chengdu University of Chinese Medicine, 610072, China.

Qiao-Hong Lin (QH)

Cancer Research Centre, Jiangxi University of Chinese Medicine, 330004, China.

Xiao-Xia Liu (XX)

Cancer Research Centre, Jiangxi University of Chinese Medicine, 330004, China.

Feng-Qin Li (FQ)

Cancer Research Centre, Jiangxi University of Chinese Medicine, 330004, China.

Hong-Da Xuan (HD)

Cancer Research Centre, Jiangxi University of Chinese Medicine, 330004, China.

Ying-Yan Bai (YY)

Cancer Research Centre, Jiangxi University of Chinese Medicine, 330004, China.

Ya-Peng Huang (YP)

Cancer Research Centre, Jiangxi University of Chinese Medicine, 330004, China.

Le Wang (L)

Cancer Research Centre, Jiangxi University of Chinese Medicine, 330004, China.

Fang Wang (F)

Cancer Research Centre, Jiangxi University of Chinese Medicine, 330004, China.

Classifications MeSH